Company Filing History:
Years Active: 2021-2024
Title: Eva Keilhauer: Innovator in Glucagon-Like Peptide Formulations
Introduction
Eva Keilhauer is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations of glucagon-like peptide 1 (GLP-1) and its analogues. With a total of 2 patents to her name, her work is paving the way for advancements in treatment methodologies.
Latest Patents
Eva's latest patents focus on methods of treatment using stable liquid formulations of GLP-1 or its analogues. These formulations are designed to provide effective treatment for various disorders or conditions. The patents emphasize the stability and efficacy of these formulations, which are crucial for their application in medical treatments.
Career Highlights
Eva Keilhauer is currently associated with Rose Pharma LLC, where she continues to innovate and develop new pharmaceutical solutions. Her expertise in the field has positioned her as a key player in the industry, contributing to advancements that can significantly impact patient care.
Collaborations
Eva collaborates with talented professionals such as Andrea Hawe and Olimpia Popko. These partnerships enhance her research and development efforts, fostering an environment of innovation and creativity.
Conclusion
Eva Keilhauer's work in the field of glucagon-like peptide formulations showcases her dedication to improving medical treatments. Her patents and collaborations reflect her commitment to advancing pharmaceutical science.